跳至主要内容
临床试验/NCT00857402
NCT00857402已完成不适用

Arginine Rich Food Supplementation as an Adjuvant Treatment Against Tuberculosis

Linkoeping University2 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2004年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
180
试验地点
2
主要终点
Final outcome according to WHO

研究概览

简要总结

The purpose of this study was to investigate if adjuvant treatment with arginine (the substrate for nitric oxide production) rich food supplements could improve clinical outcome in patients with smear positive tuberculosis by affecting nitric oxide production.

详细描述

Tuberculosis (TB) is disease of increased global public health importance. Because of emerging multi drug resistance and the long treatment duration there is a need to optimize the current chemotherapy. Host immunity is important in determining the susceptibility and outcome of disease as could be exemplified by co infection with HIV which dramatically increases the risk to develop TB.

Previous results from our group and others show that nitric oxide produced by activated macrophages from arginine might be important to control the disease. However, the relative importance of nitric oxide in human TB has been debated. In a previous study in Gondar, Ethiopia, we observed an effect of adjuvant treatment with arginine capsules on sputum smear conversion and reduction of cough. In this study we wanted to test the hypothesis based on previous observations that an arginine rich food supplementation might enhance clinical improvement in patients with smear positive tuberculosis and if this effect could be due to increased nitric oxide production.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
15 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Informed and written consent to take part in the study
  • Previously untreated and newly diagnosed smear positive Tb patients according to the WHO definitions

排除标准

  • Hospitalization
  • Pregnancy
  • Known allergy against peanuts
  • Chronic or acute disease other than tuberculosis/HIV

结局指标

主要结局

Final outcome according to WHO

时间窗: 8 months

次要结局

  • Change in Chest X-ray pattern from baseline to 2 months(2 months)
  • Weight gain from baseline until 2 months(2 months)
  • Sedimentation rate(2 months)
  • Reduction of cough from baseline to 2 months(1 and 2 months)
  • Levels of exhaled and urinary nitric oxide(First week, week 2, week 8, and month 5)
  • Sputum smear conversion(2 months)

研究者

发起方
Linkoeping University
申办方类型
Other Gov

研究点 (2)

Loading locations...

相似试验